Unknown OBSERVATIONAL NCT05334134

COVID-19: Immunological Mechanisms in Multisystem Inflammatory Syndrome in Children

Immunological Mechanisms in Multisystem Inflammatory Syndrome in Children

Sponsor: Rigshospitalet, Denmark

Conditions COVID-19 Multisystem Inflammatory Syndrome in Children SARS-CoV-2 Infection

Updated 4 times since 2022 Last updated: Apr 18, 2022 Started: Feb 1, 2020 Primary completion: Dec 31, 2022 Completion: Jun 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05334134, this observational or N/A phase trial focuses on COVID-19 and Multisystem Inflammatory Syndrome in Children and remains ongoing. Sponsored by Rigshospitalet, Denmark, it has been updated 4 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
May 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
May 2022 — May 2024 [monthly]

Recruiting

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rigshospitalet, Denmark

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark